NEVVI Medicare utilization intelligence
or

← back

Provider profile

LAU, BIEN-AIMEE M.D

Dermatology · NPI 1851699532 · FAIRFIELD, CA

1
Groups
23
Codes · 2024
4,176
Disclosed services

LAU, BIEN-AIMEE is a Dermatology in FAIRFIELD, CA, a member of 1 medical group, who billed 23 distinct codes to Medicare Part B in 2024.

Groups: SUTTER VALLEY MEDICAL FOUNDATION (SACRAMENTO, CA)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

4,176
disclosed services
23
codes billed to Medicare Part B
Prior year · CY2023 3,975 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
17003 Destruction of precancer skin growth, 2-14 growths
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
17004 Destruction of precancer skin growth, 15 or more growths
17000 Destruction of precancer skin growth, 1 growth
17110 Destruction of skin growth, 1-14 growths
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
11302 Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
11312 Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm
17282 Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm
11307 Shaving of skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm
17262 Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm
17111 Destruction of skin growth, 15 or more growths
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg
13101 Complicated repair of wound of trunk, 2.6-7.5 cm
17272 Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm
11900 Injection into skin growth, 1-7 growths
17263 Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm
11200 Removal of skin tag, 1-15 skin tags
11604 Removal of cancer skin growth of body, arms, or legs, 3.1-4.0 cm
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
11606 Removal of cancer skin growth of body, arms, or legs, more than 4.0 cm
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.